Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Mass Innovation Labs Announces Expansion to NB Development Group’s Boston Landing

Mass Innovation Labs
Posted on: 18 Dec 17

Mass Innovation Labs, the world’s leading accelerated commercialization program for the biopharmaceutical industry, today announced a major expansion into the hardware and technology sector at Boston Landing. Mass Innovation Labs will occupy 84,000 square feet of the 15-acre mixed-use development that is home to New Balance Athletics, Inc., among other world-class companies and organizations beginning in June of 2018.

The new facility will be aimed at meeting the needs of cutting-edge biotech and technology companies looking for space and operating programs that can be customized to suit their needs. Mass Innovation Labs’ groundbreaking program in Kendall Square, which opened its doors in 2015, has been providing emerging biopharmaceutical companies such as CRISPR Therapeutics and Editas Medicine with turnkey laboratory and office space and operational support that has companies up and running in a matter of weeks. The same proven and successful approach will be applied to the Boston Landing space to cater to the needs of technology companies looking for a place to grow.

“We are thrilled to extend our expertise to the technology industry, and the Boston Landing location is an ideal synergy of companies that create breakthrough products, services and technologies,” said Amrit Chaudhuri, CEO and co-founder of Mass Innovation Labs. “Through our Cambridge location, we have demonstrated that we know how to provide the right support for businesses to help them achieve success quickly. We’re excited to bring our proven model to the Boston Landing ecosystem to support technology companies as they design and develop tomorrow’s new solutions.”

”We are excited to be welcoming Mass Innovation Labs to the Boston Landing campus,” said Jim Halliday, Managing Director for New Balance Development Group, the project developer. “The addition of Mass Innovation Labs to provide an environment for technology companies to thrive in order to perform research and develop their technology advancements is at the heart of the innovational and entrepreneurial spirit of Boston Landing, its project sponsor, New Balance, and the other likeminded tenants calling Boston Landing home.”

Boston Landing, located in Boston’s Allston-Brighton neighborhood, is a mixed use development that includes office buildings, retail and restaurant space, a hotel and sports complex. The development is home to world-class organizations including New Balance, Bose, the Boston Celtics and the Boston Bruins.

For more information on Mass Innovation Labs, please visit or join us on Twitter and LinkedIn.

About Mass Innovation Labs

Mass Innovation Labs embodies an ecosystem of innovators across the biotech, pharmaceutical and technology industries. With locations emerging throughout the Boston area, we’re providing first-class space for growing companies to have access to comprehensive lab needs, including animal facilities, on-site CRO support, technological and operational needs. Our goal is to reduce the time for teams to overcome hurdles in achieving milestones. For more information, please visit or join us on Twitter and LinkedIn.

About Boston Landing

Located minutes from Downtown, Boston Landing is a smart growth project consisting of approximately 1.76 million sf. The development will include diverse property types, including three new laboratory/office buildings, an NHL regulation hockey arena for the Boston Bruins, the newly announced practice facility for the Boston Celtics, a hotel, a world class track & field / multi-sport & event center, a residential apartment building, a commuter rail station on the Framingham/Worcester-Backbay/South Station line and amenity-driven retail. The development is currently home to New Balance Athletics, Inc., Bose Corporation, Boston Bruins, Boston Celtics, Harvard Business School Publishing, Global Atlantic, Roche Diagnostics and Proteostasis.

About New Balance

New Balance, headquartered in Boston, MA has the following mission: Demonstrating responsible leadership, we build global brands that athletes are proud to wear, associates are proud to create and communities are proud to host. New Balance made its first pair of running shoes in 1938, and today owns 5 factories in Maine and Massachusetts. Manufactured in the US for over 75 years and representing a limited portion of its US sales, New Balance Made is a premium collection that contains a domestic value of 70% or greater. New Balance owns five factories in New England and one in Flimby, U.K. New Balance employs more than 5,000 associates around the globe, and in 2016 reported worldwide sales of $3.8 billion. To learn more, please visit and for the latest press information please visit

About NB Development Group

NB Development Group is a commercial real estate company based in Boston, MA. The group’s professionals bring Boston-based experience in the fields of development, permitting, construction management, asset management, leasing, and marketing. NBDG is currently managing the development of Boston Landing, a mixed-use project located along the Massachusetts Turnpike in Brighton, MA. Through expert entitlement and permitting strategies, Boston Landing is transforming a vacant industrial area into a vibrant, transit-oriented district. Boston Landing encompasses more than 15 acres of land and will include uses such as office, retail, hotel, recreation, parking, commuter rail, and residential with a total build-out of more than 2.5 million square feet.

View source version on

Business Wire

Last updated on: 18/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.